Sadako Yoshizawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sadako Yoshizawa has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Kazuhiro Tateda
11 shared publicationsYoshikazu Ishii
Center for the Planetary Health and Innovation Science (PHIS), The IDEC Institute, Hiroshima University
7 shared publicationsHinako Murakami
Department of Infection Control and Prevention, Toho University Omori Medical Center, Japan
5 shared publicationsTaito Miyazaki
Department of Infection Control and Prevention, Toho University Omori Medical Center, Japan
5 shared publications- Kotaro Aoki
Department of Microbiology and Infectious Diseases, Toho University School of Medicine, 5-21-16 Omori-nishi, Ota-ku, Tokyo 143-8540, Japan
4 shared publications Tadashi Maeda
Department of Infection Control and Prevention, Toho University Omori Medical Center, Japan
4 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
Correction for Yoshizawa et al., “One Health genomic insights into environmental and animal reservoirs of community-associated Clostridioides difficile in Japan”
Volume 92, no. 6, e00397-26, 2026, https://doi.org/10.1128/aem.00397-26. Following a reader inquiry regarding the toxin profile of ST37, we re-examined the whole-genome sequencing data and identified errors in the interpretation of tcdA detection results affecting ST37 and ST81.
- 28 July 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
Open AccessCorrection for Yoshizawa et al., “One Health genomic insights into environmental and animal reservoirs of community-associated Clostridioides difficile in Japan”
Volume 92, no. 6, e00397-26, 2026, https://doi.org/10.1128/aem.00397-26. Following a reader inquiry regarding the toxin profile of ST37, we re-examined the whole-genome sequencing data and identified errors in the interpretation of tcdA detection results affecting ST37 and ST81.
- Open Access
- 17 June 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (6) , e0039726
One Health genomic insights into environmental and animal reservoirs of community-associated Clostridioides difficile in Japan
Clostridioides difficile is a well-recognized cause of antibiotic-associated colitis. The highly pathogenic PCR ribotype(RT)027/sequence type(ST)1 strain has been prevalent since 2002, particularly in Europe and the United States, whereas strains detected in Japan primarily comprise RT018/ST17, RT369/ST81, and RT002/ST8. Community-associated C. difficile infection (CA-CDI) has increased in recent years, and an association with livestock, food, and companion animals has been suggested. This study investigated the molecular epidemiology of C. difficile in Japan, focusing on isolates from diarrheal outpatients in comparison with animal and environmental sources. A total of 401 samples were collected, including park soil and fecal samples from livestock, companion animals, wild animals, and outpatients. Overall, 63 strains were isolated. High isolation rates were observed in soil samples (19/37, 51%) and companion animals (19/64, 30%), of which 68% and 37% were toxigenic, respectively. Whole-genome sequencing revealed ST2 as the most common sequence type, followed by ST42 and ST15. No single sequence type predominated among isolates from diarrheal outpatients, and six patients met the epidemiological definition of CA-CDI. Core-genome single-nucleotide polymorphism (SNP) analysis identified close genetic relationships in two pairs of ST42 strains—one between a patient-derived isolate and park soil, and another between a canine-derived isolate and soil from a different park—using a hypothetical transmission-exclusion cutoff of Clostridioides difficile infection (CDI) is a widely recognized cause of antibiotic-associated diarrhea, and reports of community-associated CDI (CA-CDI) have risen in recent years. Understanding how C. difficile circulates outside healthcare settings is, therefore, an important public health challenge. In this study, we analyzed C. difficile isolates from outpatients with diarrhea, companion animals, and environmental sources, including soil from public parks. The organism was frequently detected in soil and pets, and genomic analyses identified closely related strains across human, animal, and soil samples. Although these findings do not indicate transmission direction, they suggest that environmental reservoirs may contribute to the broader ecology of C. difficile in the community. Our results underscore the importance of a One Health perspective integrating human, animal, and environment together when studying CA-CDI and highlight the need for further research to better understand how C. difficile persists and spreads outside hospital settings.
- 17 June 2026
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 92 (6) , e0039726
Open AccessOne Health genomic insights into environmental and animal reservoirs of community-associated Clostridioides difficile in Japan
Clostridioides difficile is a well-recognized cause of antibiotic-associated colitis. The highly pathogenic PCR ribotype(RT)027/sequence type(ST)1 strain has been prevalent since 2002, particularly in Europe and the United States, whereas strains detected in Japan primarily comprise RT018/ST17, RT369/ST81, and RT002/ST8. Community-associated C. difficile infection (CA-CDI) has increased in recent years, and an association with livestock, food, and companion animals has been suggested. This study investigated the molecular epidemiology of C. difficile in Japan, focusing on isolates from diarrheal outpatients in comparison with animal and environmental sources. A total of 401 samples were collected, including park soil and fecal samples from livestock, companion animals, wild animals, and outpatients. Overall, 63 strains were isolated. High isolation rates were observed in soil samples (19/37, 51%) and companion animals (19/64, 30%), of which 68% and 37% were toxigenic, respectively. Whole-genome sequencing revealed ST2 as the most common sequence type, followed by ST42 and ST15. No single sequence type predominated among isolates from diarrheal outpatients, and six patients met the epidemiological definition of CA-CDI. Core-genome single-nucleotide polymorphism (SNP) analysis identified close genetic relationships in two pairs of ST42 strains—one between a patient-derived isolate and park soil, and another between a canine-derived isolate and soil from a different park—using a hypothetical transmission-exclusion cutoff of Clostridioides difficile infection (CDI) is a widely recognized cause of antibiotic-associated diarrhea, and reports of community-associated CDI (CA-CDI) have risen in recent years. Understanding how C. difficile circulates outside healthcare settings is, therefore, an important public health challenge. In this study, we analyzed C. difficile isolates from outpatients with diarrhea, companion animals, and environmental sources, including soil from public parks. The organism was frequently detected in soil and pets, and genomic analyses identified closely related strains across human, animal, and soil samples. Although these findings do not indicate transmission direction, they suggest that environmental reservoirs may contribute to the broader ecology of C. difficile in the community. Our results underscore the importance of a One Health perspective integrating human, animal, and environment together when studying CA-CDI and highlight the need for further research to better understand how C. difficile persists and spreads outside hospital settings.
- 30 September 2024
- Published by Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis in Japanese Journal of Infectious Diseases
- Vol. 77 (5) , 281-284
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
The Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the clinical efficacy analysis of the CDI antimicrobials and validation of the severity classifications, patients treated with VCM or oral MNZ were included. The endpoints were CDI recurrence rate, 30-day mortality rate, and diarrhea cure rate. No significant differences were found between the VCM and oral MNZ groups regarding the CDI recurrence rate (10.4% vs. 12.7%, p = 0.707), 30-day mortality rate (12.5% vs. 5.6%, p = 0.162), and diarrhea cure rate (61.9% vs. 72.7%, p = 0.238), regardless of the severity. Treatment with oral MNZ for non-severe cases was promising, confirming the usefulness of treatment according to Japanese guidelines. Further investigation of the clinical efficacy of oral MNZ in patients with first-episode CDI and evaluation of the preferable severity classification are warranted.
- 30 September 2024
- Published by Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis in Japanese Journal of Infectious Diseases
- Vol. 77 (5) , 281-284
Clinical Efficacy of Therapeutic Agents for Clostridioides difficile Infection Based on Four Severity Classifications
The Japanese guidelines for the management of Clostridioides difficile infection (CDI) recommend metronidazole (MNZ) for non-severe cases and vancomycin (VCM) for severe cases. Here, we investigated the use of CDI antimicrobials and evaluated their clinical efficacy in four severity classifications and the validity of these classifications. A retrospective chart review was conducted on 137 inpatients with an initial positive C. difficile toxin test and initiation of CDI antimicrobials between April 2015 and March 2019. For the clinical efficacy analysis of the CDI antimicrobials and validation of the severity classifications, patients treated with VCM or oral MNZ were included. The endpoints were CDI recurrence rate, 30-day mortality rate, and diarrhea cure rate. No significant differences were found between the VCM and oral MNZ groups regarding the CDI recurrence rate (10.4% vs. 12.7%, p = 0.707), 30-day mortality rate (12.5% vs. 5.6%, p = 0.162), and diarrhea cure rate (61.9% vs. 72.7%, p = 0.238), regardless of the severity. Treatment with oral MNZ for non-severe cases was promising, confirming the usefulness of treatment according to Japanese guidelines. Further investigation of the clinical efficacy of oral MNZ in patients with first-episode CDI and evaluation of the preferable severity classification are warranted.
- 5 May 2024
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 30 (8) , 673-715
Japanese Society for infection prevention and control guide to Clostridioides difficile infection prevention and control
- 5 May 2024
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 30 (8) , 673-715
Japanese Society for infection prevention and control guide to Clostridioides difficile infection prevention and control
- Open Access
- 11 April 2024
- Published by Elsevier in American Journal of Infection Control
- Vol. 52 (7) , 801-806
The outbreak of multispecies carbapenemase-producing Enterobacterales associated with pediatric ward sinks: IncM1 plasmids act as vehicles for cross-species transmission
- 11 April 2024
- Published by Elsevier in American Journal of Infection Control
- Vol. 52 (7) , 801-806
Open AccessThe outbreak of multispecies carbapenemase-producing Enterobacterales associated with pediatric ward sinks: IncM1 plasmids act as vehicles for cross-species transmission
- Open Access
- 18 December 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-5
Pseudomonas otitidis bacteremia in an immunocompromised patient with cellulitis: case report and literature review
Background: Pseudomonas otitidis belongs to the genus Pseudomonas and causes various infections, including ear, skin, and soft tissue infections. P. otitidis has a unique susceptibility profile, being susceptible to penicillins and cephalosporins but resistant to carbapenems, due to the production of the metallo-β-lactamase called POM-1. This revealed genetic similarities with Pseudomonas aeruginosa, which can sometimes lead to misidentification. Case presentation: We report the case of a 70-year-old Japanese male who developed cellulitis and bacteremia during chemotherapy for multiple myeloma. He was initially treated with meropenem, but blood culture later revealed gram-negative bacilli identified as P. otitidis using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Carbapenem resistance was predicted from previous reports; therefore, we switched to dual therapy with levofloxacin and cefepime, and favorable treatment results were obtained. Conclusion: This is the first reported case of P. otitidis cellulitis and bacteremia in an immunocompromised patient. Carbapenems are typically used in immunocompromised patients and P. otitidis is often resistant to it. However, its biochemical properties are similar to those of Pseudomonas aeruginosa; therefore, its accurate identification is critical. In the present study, we rapidly identified P. otitidis using MALDI-TOF MS and switched from carbapenems to an appropriate antimicrobial therapy, resulting in a successful outcome.
- 18 December 2023
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 23 (1) , 1-5
Open AccessPseudomonas otitidis bacteremia in an immunocompromised patient with cellulitis: case report and literature review
Background: Pseudomonas otitidis belongs to the genus Pseudomonas and causes various infections, including ear, skin, and soft tissue infections. P. otitidis has a unique susceptibility profile, being susceptible to penicillins and cephalosporins but resistant to carbapenems, due to the production of the metallo-β-lactamase called POM-1. This revealed genetic similarities with Pseudomonas aeruginosa, which can sometimes lead to misidentification. Case presentation: We report the case of a 70-year-old Japanese male who developed cellulitis and bacteremia during chemotherapy for multiple myeloma. He was initially treated with meropenem, but blood culture later revealed gram-negative bacilli identified as P. otitidis using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Carbapenem resistance was predicted from previous reports; therefore, we switched to dual therapy with levofloxacin and cefepime, and favorable treatment results were obtained. Conclusion: This is the first reported case of P. otitidis cellulitis and bacteremia in an immunocompromised patient. Carbapenems are typically used in immunocompromised patients and P. otitidis is often resistant to it. However, its biochemical properties are similar to those of Pseudomonas aeruginosa; therefore, its accurate identification is critical. In the present study, we rapidly identified P. otitidis using MALDI-TOF MS and switched from carbapenems to an appropriate antimicrobial therapy, resulting in a successful outcome.
- Open Access
- 6 September 2023
- Published by Springer Nature in Research Square
Pseudomonas otitidis bacteremia in an immunocompromised patient with cellulitis: case report and literature review
Background: Pseudomonas otitidis belongs to the genus Pseudomonas and causes various infections, including ear, skin, and soft tissue infections. P. otitidishas a unique susceptibility profile, being susceptible to penicillins and cephalosporins but resistant to carbapenems, due to the production of the metallo-β-lactamase called POM-1. This revealed genetic similarities with Pseudomonas aeruginosa, which can sometimes lead to misidentification. Case presentation: We report the case of a 70-year-old Japanese male who developed cellulitis and bacteremia during chemotherapy for multiple myeloma. He was initially treated with meropenem, but blood culture later revealed gram-negative bacilli identified as P. otitidis using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Carbapenem resistance was predicted from previous reports; therefore, we switched to dual therapy with levofloxacin and cefepime, and favorable treatment results were obtained. Conclusion: This is the first reported case of P. otitidis cellulitis and bacteremia in an immunocompromised patient. Carbapenems are typically used in immunocompromised patients and P. otitidis is often resistant to it. However, its biochemical properties are similar to those of Pseudomonas aeruginosa; therefore, its accurate identification is critical. In the present study, we rapidly identified P. otitidis using MALDI-TOF MS and switched from carbapenems to an appropriate antimicrobial therapy, resulting in a successful outcome.
- 6 September 2023
- Published by Springer Nature in Research Square
Open AccessPseudomonas otitidis bacteremia in an immunocompromised patient with cellulitis: case report and literature review
Background: Pseudomonas otitidis belongs to the genus Pseudomonas and causes various infections, including ear, skin, and soft tissue infections. P. otitidishas a unique susceptibility profile, being susceptible to penicillins and cephalosporins but resistant to carbapenems, due to the production of the metallo-β-lactamase called POM-1. This revealed genetic similarities with Pseudomonas aeruginosa, which can sometimes lead to misidentification. Case presentation: We report the case of a 70-year-old Japanese male who developed cellulitis and bacteremia during chemotherapy for multiple myeloma. He was initially treated with meropenem, but blood culture later revealed gram-negative bacilli identified as P. otitidis using matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS). Carbapenem resistance was predicted from previous reports; therefore, we switched to dual therapy with levofloxacin and cefepime, and favorable treatment results were obtained. Conclusion: This is the first reported case of P. otitidis cellulitis and bacteremia in an immunocompromised patient. Carbapenems are typically used in immunocompromised patients and P. otitidis is often resistant to it. However, its biochemical properties are similar to those of Pseudomonas aeruginosa; therefore, its accurate identification is critical. In the present study, we rapidly identified P. otitidis using MALDI-TOF MS and switched from carbapenems to an appropriate antimicrobial therapy, resulting in a successful outcome.
- 22 January 2022
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 102 (4) , 115640
Evaluation of risk factors for uric acid elevation in COVID-19 patients treated with favipiravir
- 22 January 2022
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 102 (4) , 115640
Evaluation of risk factors for uric acid elevation in COVID-19 patients treated with favipiravir
- 25 August 2021
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 88 (4) , 380-383
IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- 25 August 2021
- Published by Medical Association of Nippon Medical School in Journal of Nippon Medical School
- Vol. 88 (4) , 380-383
IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies
- Open Access
Immunochromatographic test for the detection of SARS-CoV-2 in saliva
We evaluated the rapid immunochromatographic test for SARS-CoV-2 antigen detection using 16 saliva specimens collected from 6 COVID-19 hospitalized patients, and detected N-antigen in 4 of 7 RT-PCR positive specimens. The POCT antigen test using saliva is highly considered to be a game-changer for COVID-19 diagnosis.
Open AccessImmunochromatographic test for the detection of SARS-CoV-2 in saliva
We evaluated the rapid immunochromatographic test for SARS-CoV-2 antigen detection using 16 saliva specimens collected from 6 COVID-19 hospitalized patients, and detected N-antigen in 4 of 7 RT-PCR positive specimens. The POCT antigen test using saliva is highly considered to be a game-changer for COVID-19 diagnosis.